CANBRIDGE PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss
The total revenue of 1228 for the last semiannual is 64.63 M HKD, and it's 32.73% higher compared to the previous semiannual. The net income of H2 23 is -173.58 M HKD.